Houston, United States
VenoStent, Inc. is a clinical-stage medical device and tissue engineering company that specializes in developing bioresorbable smart polymer scaffolds designed to enhance the outcomes of vascular surgery. This venture-backed company, founded in 2017, is headquartered in the United States and operates within a range of industries including Biotechnology, Health Care, Life Sciences, Manufacturing, and Medical Devices.
In its most recent round of funding, VenoStent secured a $4.00M Series A investment on June 27, 2024. The round was led by notable investors such as Good Growth Capital, Norwest Venture Partners, and IAG Capital Partners. This strategic infusion of capital is expected to support their ongoing clinical trials and facilitate the launch of their groundbreaking bioabsorbable wraps in the vascular surgery field.
With its innovative approach and solid backing from prominent investors, VenoStent appears poised to make significant advancements in healthcare technology.
